Boston Scientific Corporation (NYSE:BSX) is one of the best mid-cap growth stocks to buy right now. On January 16, ...

Boston Scientific said it will pay $374 a share in cash and stock for Penumbra, which makes products to remove blood clots ...

Boston Scientific Corporation and Penumbra, Inc. announced that the companies have entered into a definitive agreement under ...

Boston Scientific acquires Valencia Technologies' eCoin bladder dysfunction device, expanding into the $30M+ overactive ...

Polen Capital, an investment management company, released its “Polen Focus Growth Strategy” third-quarter 2025 investor letter. A copy of the letter can be downloaded here. The equity market continued ...

Boston Scientific is a 'forever stock' due to management foresight, robust R&D, and leadership in AI-driven medical devices. Despite a weak valuation grade, its strong financials, global expansion, ...

Worcester-based Hanover Insurance, Marlborough-based Boston Scientific, and Milford-based Waters Corp. have been named to the Human Rights Campaign Foundation’s Equality 100 Award list. Boston ...

Fitch expects Boston Scientific to achieve double-digit top-line growth over the rating horizon, forecasting 2025 revenue of approximately $20 billion, representing roughly 20% growth compared to the ...

Stryker Corporation was hit with a patent infringement lawsuit on July 2 in New Jersey District Court. The complaint, filed by Arnold & Porter Kaye Scholer on behalf of Boston Scientific and Relievant ...

Boston Scientific, a Marlborough medical device manufacturer, has officially closed its acquisition of California medical device maker Silk Road Medical, almost exactly three months to the day since ...